DOI: 10.1167/tvst.4.4.4
Editorial
ARVO Embraces Open Access As many readers of Translational Vision Science & Technology know, ARVO has been committed to making scientific information readily available to the eye and vision science community. Investigative Ophthalmology & Visual Science, for example, already has a 6-month embargo date, and the Journal of Vision and Translational Vision Science & Technology always have had free access, although the copyright has been held by ARVO. As of January 1, 2016, all ARVO journals will be open access. Flat article pricing will apply to all manuscripts submitted on or after December 1, 2015. After careful consideration, the ARVO Board of Trustees has set the flat fee at $1,850. A discount of $350 will be offered to corresponding authors who are ARVO members at the time of article acceptance. All papers published on or after January 1, 2016 will be open access based on a chosen license. The default license is
1
a CC BY-NC-ND license (https://creativecommons. org/licenses/by-nc-nd/4.0/). Some agencies require a different open access license—CC BY (https:// creativecommons.org/licenses/by/4.0/)—and additional fees will apply in these cases. ARVO will hold the copyright to all content published before January 1, 2016, but this content will be free access. If you have any additional questions regarding the open access policy please check the ARVO website at http://arvojournals.org/SS/openaccess.aspx. Marco A. Zarbin Editor-in-Chief, TVST University of Medicine and Dentistry of New Jersey Institute of Ophthalmology and Visual Science Newark, New Jersey
TVST j 2015 j Vol. 4 j No. 4 j Article 4
Editorial
ARVO Embraces Open Access As many readers of Translational Vision Science & Technology know, ARVO has been committed to making scientific information readily available to the eye and vision science community. Investigative Ophthalmology & Visual Science, for example, already has a 6-month embargo date, and the Journal of Vision and Translational Vision Science & Technology always have had free access, although the copyright has been held by ARVO. As of January 1, 2016, all ARVO journals will be open access. Flat article pricing will apply to all manuscripts submitted on or after December 1, 2015. After careful consideration, the ARVO Board of Trustees has set the flat fee at $1,850. A discount of $350 will be offered to corresponding authors who are ARVO members at the time of article acceptance. All papers published on or after January 1, 2016 will be open access based on a chosen license. The default license is
1
a CC BY-NC-ND license (https://creativecommons. org/licenses/by-nc-nd/4.0/). Some agencies require a different open access license—CC BY (https:// creativecommons.org/licenses/by/4.0/)—and additional fees will apply in these cases. ARVO will hold the copyright to all content published before January 1, 2016, but this content will be free access. If you have any additional questions regarding the open access policy please check the ARVO website at http://arvojournals.org/SS/openaccess.aspx. Marco A. Zarbin Editor-in-Chief, TVST University of Medicine and Dentistry of New Jersey Institute of Ophthalmology and Visual Science Newark, New Jersey
TVST j 2015 j Vol. 4 j No. 4 j Article 4
